The Weekly Litigation News Digest is now live. Subscribe now

Pneumococcal Polysaccharide Conjugate Vaccine - EP3017827

The patent EP3017827 was granted to Glaxosmithkline on Nov 7, 2018. The application was originally filed on Dec 20, 2006 under application number EP15195398A. The patent is currently recorded with a legal status of "Revoked".

EP3017827

GLAXOSMITHKLINE
Application Number
EP15195398A
Filing Date
Dec 20, 2006
Status
Revoked
Apr 4, 2025
Publication Date
Nov 7, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERAug 6, 2019PFIZER -
SANOFI PASTEUR INCSANOFI AVENTIS DEUTSCHLAND GMBHSANOFI WINTHROP INDUSTRIESAug 6, 2019ZWICKER -
SK BIOSCIENCEAug 6, 2019ZWICKER -

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP0072513
OPPOSITIONEP0497524
OPPOSITIONEP0497525
OPPOSITIONEP3017827
OPPOSITIONUS4619828
OPPOSITIONUS5565204
OPPOSITIONWO03051392
OPPOSITIONWO2006110381
OPPOSITIONWO2010080484
OPPOSITIONWO9508348
SEARCHUS2003147922
SEARCHWO03051392
SEARCHWO2006110381

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents